Halofantrine
Back to searchMolecule Structure
Scientific Name
Halofantrine
Description of the Drug
Halofantrine is an antimalarial used for the treatment of severe malaria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01218
http://www.drugbank.ca/drugs/DB01218
Brand Name(s)
Not Available
Company Owner(s)
Glaxosmithkline
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Ferriprotoporphyrin IX | SMALL MOLECULE | INHIBITOR | CHEMBL613897 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL43795 | |
| PharmGKB | PA449839 | |
| Human Metabolome Database | HMDB0015349 | |
| DrugBank | DB01218 | |
| PubChem: Thomson Pharma | 14859927 | |
| PubChem | 37393 | |
| LINCS | LSM-5072 | |
| Nikkaji | J18.879D | |
| BindingDB | 79214 | |
| EPA CompTox Dashboard | DTXSID0023119 | |
| DrugCentral | 1350 | |
| ChemicalBook | CB6377605 | |
| Guide to Pharmacology | 10019 | |
| rxnorm | HALOFANTRINE HYDROCHLORIDE | HALOFANTRINE |
| ChEBI | 94392 |
